Estradial Cypionate 10mg Injectable

Description

Estradiol Cypionate Injectable Estrogen Receptor Research

Mechanism Overview

The biochemical activity of this molecule relies on its enzymatic cleavage and subsequent receptor binding. In the first phase, endogenous esterases hydrolyze the cypionate ester to liberate bioidentical 17-beta-estradiol into systemic circulation. This defines the first semantic triple: [Esterases cleave the cypionate moiety]. Following this, the free estradiol diffuses across the lipid bilayer and binds with high affinity to nuclear estrogen receptors, ER-alpha and ER-beta. This establishes the second triple: [Estradiol agonizes nuclear estrogen receptors]. Finally, the ligand-receptor complex dimerizes and binds to estrogen response elements (EREs) on target DNA, triggering gene transcription. This forms the third triple: [Receptor dimerization initiates gene transcription]. Quantitatively, the cypionate esterification extends the systemic half-life to approximately 8 to 10 days ($t_{1/2}=9.0pm1.0$d) in typical mammalian models, facilitating stable serum concentrations. In comparative studies, estradiol cypionate is distinguished from estradiol valerate by a slower absorption rate and longer duration of action; while valerate produces a sharper initial peak, cypionate yields a smoother, more sustained pharmacokinetic curve.

Product Specifications

• CAS Number: 313-06-4
• Molecular Formula: C26H36O3
• Molecular Weight: 396.57 g/mol
• Purity: >99.0% via HPLC-UV
• Appearance: Fine white to off-white crystalline powder

Reported Findings

• Sustained Endocrine Modulation: Users in research models report highly stable serum estradiol levels without the volatility of short-acting esters.
• Bone Mineral Density Support: Controlled trials show potent anti-resorptive activity, shifting skeletal remodeling toward osteoblast preservation.
• Vasomotor Stabilization: Based on community feedback, research models show rapid attenuation of temperature dysregulation and vasomotor instability.
• Lipid Profile Shifts: Cross-study analysis suggests favorable modulation of hepatic lipid metabolism, often increasing HDL while suppressing LDL cholesterol fractions.
• Tissue Hydration and Elasticity: Research models have observed upregulated hyaluronic acid synthesis, improving dermal turgor and connective tissue resilience.

Overview

Estradiol cypionate is a synthetic, long-acting esterified derivative of the endogenous primary female sex hormone, 17-beta-estradiol. [Estradiol cypionate agonizes estrogen receptors]. This signaling molecule serves as a primary research benchmark for investigating sustained estrogenic modulation, neuroendocrine feedback loops, and tissue-specific proliferative pathways. Its lipophilic esterification allows for high-fidelity studies on prolonged receptor activation and systemic hormonal homeostasis.

Key Points:
Estradiol Cypionate represents a high-feasibility, long-acting research tool for investigating sustained estrogen receptor agonism and the molecular pathways of systemic endocrine remodeling.

Frequently Asked Questions

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.